Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach

Peng Zhan; Wen‐Ming Chen; Zhenyu Li; Xiao Li; Xuwang Chen; Ye Tian; Christophe Pannecouque; De Clercq Erik; Xinyong Liu

doi:10.1016/j.bmc.2012.09.058

Back

Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach

Article 2012 en

Related publications

Article2013

Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisosterism approach

Yuning Song, Peng Zhan, Dongwei Kang, Xiao Li, Ye Tian, Zhenyu Li, Xuwang Chen, Wen‐Ming Chen, Christophe Pannecouque, De Clercq Erik, Xinyong Liu

Article2011

Arylazolylthioacetanilide. Part 8☆: Design, synthesis and biological evaluation of Novel 2-(2-(2,4-Dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides As Potent HIV-1 inhibitors

Peng Zhan, Xuwang Chen, Xiao Li, Dongyue Li, Ye Tian, Wenwen Chen, Christophe Pannecouque, De Clercq Erik, Xinyong Liu

Article2016

Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach

Xueyi Lu, Xiao Li, Jiapei Yang, Boshi Huang, Dongwei Kang, Fabao Zhao, Zhongxia Zhou, De Clercq Erik, Dirk Daelemans, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Article2016

Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5‐b]pyridin‐2‐ylthioacetanilides as Potent HIV NNRTIs Via a Structure‐based Bioisosterism Approach

Xiao Li, Boshi Huang, Zhongxia Zhou, Ping Gao, Christophe Pannecouque, Dirk Daelemans, De Clercq Erik, Peng Zhan, Xinyong Liu

Article2014

Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors

Xiao Li, Xueyi Lu, Wen‐Ming Chen, Huiqing Liu, Peng Zhan, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Xinyong Liu

Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach

Discussion(0)

Related publications

Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisosterism approach

Arylazolylthioacetanilide. Part 8☆: Design, synthesis and biological evaluation of Novel 2-(2-(2,4-Dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides As Potent HIV-1 inhibitors

Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach

Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5‐b]pyridin‐2‐ylthioacetanilides as Potent HIV NNRTIs Via a Structure‐based Bioisosterism Approach

Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors